Heron Therapeutics Adjusts Q2 2025 Earnings Announcement Date

Author: Dylan Bailey Updated: 08-08-2025 06:29 AM

Heron Therapeutics Announces Rescheduled Earnings Call for Q2 2025

Heron Therapeutics, Inc. (NASDAQ: HRTX), a leading biotechnology company dedicated to enhancing patient care through innovative medical solutions, has decided to change the date of its second quarter 2025 earnings release. The Company will now hold its live conference call and webcast on Friday, August 8, 2025, at 8:30 a.m. ET, allowing stakeholders to engage in discussions about the latest financial results and significant updates in the business.

Details of the Upcoming Conference Call

Participants can join the conference call by using a registration link that will provide them with dial-in information. For an optimal experience, attendees are encouraged to connect fifteen minutes prior to the start time. Additionally, this important call will be accessible via webcast under the Investor Relations section of Heron Therapeutics' website. An archive of the call will be available for 60 days, ensuring everyone has the opportunity to catch up on the insights shared.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is committed to revolutionizing the treatment landscape for patients in acute and oncology care through the development and commercialization of groundbreaking therapeutic products. With a focus on advanced science and proprietary technologies, Heron is dedicated to improving the quality of life for patients by providing innovative treatment options. To explore further about their ongoing initiatives and products, visit www.herontx.com.

Investor Relations Team

If you would like to reach out for more information or inquiries, please contact:

Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
Phone: 858-251-4400

Frequently Asked Questions

What is the new date for Heron Therapeutics' Q2 2025 earnings release?

The new date for the earnings release is Friday, August 8, 2025.

How can I participate in the conference call?

Participants can access the conference call through a registration link that provides dial-in details.

Where can I find the webcast of the conference call?

The webcast will be available under the Investor Relations section of Heron Therapeutics' website.

Who should I contact for more information regarding Heron Therapeutics?

You can contact Ira Duarte, Executive Vice President, Chief Financial Officer, at iduarte@herontx.com.

What is the mission of Heron Therapeutics?

Heron Therapeutics aims to enhance patient care by developing and commercializing therapeutic innovations that address significant medical needs.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.